Milène Volpato

Summary

Affiliation: University of Bradford
Country: UK

Publications

  1. ncbi request reprint Tailoring targeted therapy to individual patients: lessons to be learnt from the development of mitomycin C
    Milène Volpato
    Institute of Cancer Therapeutics, University of Bradford, Bradford BD7 1DP, UK
    Cancer Genomics Proteomics 4:175-86. 2007
  2. ncbi request reprint Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system
    Milène Volpato
    Institute of Cancer Therapeutics, University of Bradford, Bradford BD7 1DP, United Kingdom
    Mol Cancer Ther 6:3122-30. 2007
  3. ncbi request reprint Formation of DNA interstrand cross-links as a marker of Mitomycin C bioreductive activation and chemosensitivity
    Milène Volpato
    Cancer Research Unit, Tom Connors Cancer Research Centre, University of Bradford, Bradford BD7 1DP, UK
    Eur J Cancer 41:1331-8. 2005

Detail Information

Publications3

  1. ncbi request reprint Tailoring targeted therapy to individual patients: lessons to be learnt from the development of mitomycin C
    Milène Volpato
    Institute of Cancer Therapeutics, University of Bradford, Bradford BD7 1DP, UK
    Cancer Genomics Proteomics 4:175-86. 2007
    ....
  2. ncbi request reprint Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system
    Milène Volpato
    Institute of Cancer Therapeutics, University of Bradford, Bradford BD7 1DP, United Kingdom
    Mol Cancer Ther 6:3122-30. 2007
    ..Further development of this concept to fine-tune substrate specificity for specific reductases and/or the inclusion of alternative therapeutic agents is warranted...
  3. ncbi request reprint Formation of DNA interstrand cross-links as a marker of Mitomycin C bioreductive activation and chemosensitivity
    Milène Volpato
    Cancer Research Unit, Tom Connors Cancer Research Centre, University of Bradford, Bradford BD7 1DP, UK
    Eur J Cancer 41:1331-8. 2005
    ..Further studies are required to assess whether this approach as a mean of prediction has practical applications in vivo...